PHIO — Phio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing
Phio Pharmaceuticals Corp expected to post a loss of 36 cents a share - Earnings Preview
Brief: Phio Pharmaceuticals Appoints Lisa Carson As Principal Financial Officer - SEC Filing
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
U.S. STOCKS ON THE MOVE-Owens & Minor ,Scinai , Vermilion Energy
U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker Barrel
Phio Pharma up after H.C. Wainwright assumes coverage with 'buy' rating
Phio Pharmaceuticals Corp reports results for the quarter ended December 31 - Earnings Summary
Phio Pharmaceuticals Corp expected to post a loss of $1.23 a share - Earnings Preview
Brief: Phio Pharmaceuticals Positive Safety Monitoring Committee Recommendation To Continue To Third Dose Cohort In Its Clinical Study Of Ph-762
Phio Pharmaceuticals Corp expected to post a loss of $4.14 a share - Earnings Preview
Phio Pharmaceuticals Corp expected to post a loss of $4.59 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Golar LNG, gold miners, Big Tech
U.S. STOCKS ON THE MOVE-Golar LNG, gold miners, Big Tech
Phio Pharma falls on ending share purchase agreement with Triton Funds
Brief: Phio Pharmaceuticals Terminates Share Purchase Agreement With Triton